{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:23:04Z","timestamp":1785763384413,"version":"3.56.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":570,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Veterans Affairs Rehabilitation Research & Development","award":["RX003666"],"award-info":[{"award-number":["RX003666"]}]},{"name":"Veterans Affairs Rehabilitation Research & Development","award":["RX003666"],"award-info":[{"award-number":["RX003666"]}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Chronic lung diseases (CLDs) have been variably associated with a risk for more severe manifestations and death with coronavirus disease (COVID-19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the risk overall and by type of CLD for severity of COVID-19 outcomes in a U.S. national cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from the Veterans Health Administration, we determined the risk associated with CLDs, including chronic obstructive pulmonary disease (COPD) (mild or severe), asthma (mild, active, or severe), idiopathic pulmonary fibrosis (IPF), sarcoidosis, and other interstitial lung diseases (ILDs) for outcomes among veterans with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive tests between March 1, 2020 and April 30, 2021. We used multinomial regression to estimate risk of four mutually exclusive COVID-19 outcomes within 30\u2009days: outpatient management, hospitalization, hospitalization with indicators of critical illness, or death. We calculated the overall proportion with each outcome, the absolute risk difference, and risk ratios for each outcome between those with and without CLD. We also describe clinical and laboratory abnormalities by CLD in those hospitalized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 208,283 veterans with COVID-19; 35,587 (17%) had CLD. Compared with no CLD, veterans with CLD were older and had more comorbidities. Hospitalized veterans with CLD were more likely to have low temperature, mean arterial pressure, oxygen saturation, and leukopenia and thrombocytopenia and were more likely to receive oxygen, mechanical ventilation, and vasopressors. Veterans with CLD were significantly less likely to have mild COVID-19 (\u22124.5%; adjusted risk ratio [aRR], 0.94; 95% confidence interval [CI], 0.94\u20130.95), and more likely to have a moderate (+2.5%; aRR, 1.21; 95% CI, 1.18\u20131.24), critical (+1.4%; aRR, 1.38; 95% CI, 1.32\u20131.45), or fatal (+0.7%; aRR, 1.15; 95% CI, 1.10\u20131.20) outcome. IPF was most strongly associated with COVID-19 severity, especially mortality (+3.2%; aRR, 1.69; 95% CI, 1.46\u20131.96), followed by other ILDs and COPD, whereas asthma was less likely to be associated with severity of COVID-19. In veterans younger than age 65\u2009years, worse COVID-19 outcomes were generally more likely with IPF, sarcoidosis, and other ILDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Veterans who had CLD, particularly IPF, other ILDs, and COPD, had an increased probability of more severe 30-day outcomes with COVID-19. These results provide insight into the absolute and relative risk of different CLDs with severity of COVID-19 outcomes and can help inform considerations of healthcare utilization and prognosis.<\/jats:p>\n                    <jats:p>Observational clinical epidemiology study registered with www.clinicaltrials.gov (NCT04628039).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202311-974oc","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:21:31Z","timestamp":1711444891000},"page":"1034-1043","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":10,"title":["COVID-19 Severity and Mortality in Veterans with Chronic Lung Disease"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-0371","authenticated-orcid":false,"given":"Kristina","family":"Crothers","sequence":"first","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-8051","authenticated-orcid":false,"given":"Scott V.","family":"Adams","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6897-8003","authenticated-orcid":false,"given":"Aaron P.","family":"Turner","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"},{"name":"Department of Rehabilitation Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3482-4030","authenticated-orcid":false,"given":"Lisa","family":"Batten","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Nikzad","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Kundzins","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-1117","authenticated-orcid":false,"given":"Vincent S.","family":"Fan","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Healthcare System, Seattle, Washington; and"},{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"2026012203160229400_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jaip.2021.02.041","article-title":"Chronic respiratory diseases and the outcomes of COVID-19: a nationwide retrospective cohort study of 39,420 cases","volume":"9","author":"Guan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026012203160229400_bib2","doi-asserted-by":"crossref","first-page":"2101209","DOI":"10.1183\/13993003.01209-2021","article-title":"Asthma and COVID-19 risk: a systematic review and meta-analysis","volume":"59","author":"Sunjaya","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012203160229400_bib3","doi-asserted-by":"crossref","first-page":"e0276774","DOI":"10.1371\/journal.pone.0276774","article-title":"Effect of asthma, COPD, and ACO on COVID-19: a systematic review and meta-analysis","volume":"17","author":"Uruma","year":"2022","journal-title":"PLoS One"},{"key":"2026012203160229400_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmjebm-2021-111788","article-title":"Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses","volume":"27","author":"Otunla","year":"2022","journal-title":"BMJ Evid Based Med"},{"key":"2026012203160229400_bib5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S2213-2600(21)00095-3","article-title":"Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study","volume":"9","author":"Aveyard","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026012203160229400_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026012203160229400_bib7","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.eclinm.2021.100789","article-title":"COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis","volume":"33","author":"Gerayeli","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026012203160229400_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12890-023-02761-5","article-title":"Asthma and COPD as co-morbidities in patients hospitalised with Covid-19 disease: a global systematic review and meta-analysis","volume":"23","author":"Finnerty","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026012203160229400_bib9","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2147\/COPD.S386463","article-title":"chronic obstructive pulmonary disease is not associated with in-hospital mortality in COVID-19: an observational cohort analysis","volume":"17","author":"Toppen","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203160229400_bib10","doi-asserted-by":"crossref","first-page":"107064","DOI":"10.1016\/j.rmed.2022.107064","article-title":"Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease","volume":"206","author":"Myers","year":"2023","journal-title":"Respir Med"},{"key":"2026012203160229400_bib11","doi-asserted-by":"crossref","first-page":"e000969","DOI":"10.1136\/bmjresp-2021-000969","article-title":"Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis","volume":"8","author":"Naqvi","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"2026012203160229400_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiaa767","article-title":"Natural history of coronavirus disease 2019: risk factors for hospitalizations and deaths among &gt;26 million US Medicare beneficiaries","volume":"223","author":"Izurieta","year":"2021","journal-title":"J Infect Dis"},{"key":"2026012203160229400_bib13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203160229400_bib14","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1513\/AnnalsATS.202202-137RL","article-title":"Mortality among patients with COVID-19 and different interstitial lung disease subtypes: a multicenter cohort study","volume":"19","author":"Zhao","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203160229400_bib15","doi-asserted-by":"crossref","first-page":"106538","DOI":"10.1016\/j.rmed.2021.106538","article-title":"Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: a multicenter retrospective research network study","volume":"187","author":"Hadi","year":"2021","journal-title":"Respir Med"},{"key":"2026012203160229400_bib16","doi-asserted-by":"crossref","first-page":"2004474","DOI":"10.1183\/13993003.04474-2020","article-title":"Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study","volume":"58","author":"Beltramo","year":"2021","journal-title":"Eur Respir J"},{"key":"2026012203160229400_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12874-023-01882-z","article-title":"Design and analysis of outcomes following SARS-CoV-2 infection in veterans","volume":"23","author":"Smith","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"2026012203160229400_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1513\/AnnalsATS.202211-942PS","article-title":"Interstitial lung disease in veterans: leveraging big data to bridge evidence and practice gaps","volume":"20","author":"Kaul","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203160229400_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1513\/AnnalsATS.202205-458OC","article-title":"Trends and rural-urban differences in the initial prescription of low-value inhaled corticosteroids among U.S. veterans with chronic obstructive pulmonary disease","volume":"20","author":"Duan","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203160229400_bib20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/infdis\/jiac182","article-title":"Impact of coronavirus disease 2019 (COVID-19) severity on long-term events in United States Veterans using the Veterans Affairs Severity Index for COVID-19 (VASIC)","volume":"226","author":"Galloway","year":"2022","journal-title":"J Infect Dis"},{"key":"2026012203160229400_bib21","doi-asserted-by":"crossref","first-page":"e2022310","DOI":"10.1001\/jamanetworkopen.2020.22310","article-title":"Risk factors for hospitalization, mechanical ventilation, or death among 10\u2009131 US veterans with SARS-CoV-2 infection","volume":"3","author":"Ioannou","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026012203160229400_bib22","doi-asserted-by":"crossref","first-page":"2102532","DOI":"10.1183\/13993003.02532-2021","article-title":"Veterans Aging Cohort Study Clinical COVID-19 Working Group. Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support","volume":"60","author":"Crothers","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012203160229400_bib23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ntr\/ntr206","article-title":"Validating smoking data from the Veteran\u2019s Affairs Health Factors dataset, an electronic data source","volume":"13","author":"McGinnis","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"2026012203160229400_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"2026012203160229400_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12890-022-02230-5","article-title":"Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma","volume":"22","author":"Murphy","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2026012203160229400_bib26","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa2209421","article-title":"Inhaled fluticasone furoate for outpatient treatment of Covid-19","volume":"389","author":"Boulware","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/7\/1034\/66141634\/annalsats_21_7_1034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/7\/1034\/66141634\/annalsats_21_7_1034.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:17:15Z","timestamp":1769069835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/7\/1034\/8405863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202311-974oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"2023-11-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}